Macrogenics

MGNXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$256.795 M

$4.04 +0.75%

Close of 7 Aug 2026

Revenue

$149.5M

#2401 by revenue

Earnings

-$74.6K

Loss-making

Shares outstanding

63,555,837

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#249ProQR TherapeuticsPRQR$264.6M
#250Cartesian TherapeuticsRNAC$260.0M
#251MacrogenicsMGNX$256.8M
#252Whitehawk TherapeuticsWHWK$256.0M
#253Akebia TherapeuticsAKBA$252.1M

Where these numbers come from

Share counts and financials for Macrogenics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.